Biolam Groupe
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Biolam Groupe - overview
Established
2000
Location
Amiens, -, France
Primary Industry
Healthcare
About
Based in Amiens, France, and founded in 2000, Biolam Groupe also known as Biolam laboratory, and Biolam 80, operates as a clinical testing laboratory company. In January 2020, the firm’s stakes were acquired by Gimv along with the participation of Daniel Attias and in December 2022, Gimv sold the stakes of Biolam to its founding team. Biolam as of December 2022, has a network of 30 labs and 4 technical platforms. The company operates as a chain of laboratories in medical biology and offers medical analysis, screening for SARS-COV2 of Covid 19, blood tests and biology and biological analyses, etc.
The company provides patient reports through a results server for patients and healthcare professionals as well as through secure email, Apicrypt messaging, or fax.
Current Investors
Gimv
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Medical Devices & Equipment
Website
www.groupebiolam.fr
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Biolam Groupe - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sale to Management | Completed | Biolam Groupe | - | ||||||||
| Buyout | Completed | Biolam Groupe | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.